Mina Sooch
Equibles does not estimate personal net worth.
About Mina Sooch
Mina Sooch was last confirmed as Board Member at Opus Genetics, Inc. (IRD) in a filing dated April 27, 2022. Earlier roles on record: CEO at Opus Genetics, Inc. (IRD) until April 19, 2023. Opus Genetics, Inc. reported in an 8-K filed April 21, 2023 that Mina Sooch was terminated as President and Chief Executive Officer, effective April 19, 2023. The proxy statement of Opus Genetics, Inc. reports total compensation of $2,811,138 for Mina Sooch in fiscal 2023, including a base salary of $168,831. Disclosed compensation is on record for 5 fiscal years.
“On April 19, 2023, Ocuphire Pharma, Inc. (the "Company") terminated the employment of Mina Sooch, the President and Chief Executive Officer of the Company.”
Affiliation history
-
Start not stated–2022-04-27
Last confirmed by a filing; no departure on record
-
Start not stated–2023-04-19
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Opus Genetics, Inc. (IRD) | Former Chief Executive Officer and President | $168,831 | $2,811,138 |
| 2022 | Opus Genetics, Inc. (IRD) | Former Chief Executive Officer and President | $550,000 | $1,341,595 |
| 2021 | Opus Genetics, Inc. (IRD) | Former Chief Executive Officer and President | $525,000 | $801,030 |
| 2020 | Opus Genetics, Inc. (IRD) | Chief Executive Officer and President | $81,667 | $486,887 |
| 2019 | Opus Genetics, Inc. (IRD) | Chief Executive Officer and President | — | — |